This is a Validated Antibody Database (VAD) review about human MUL1, based on 2 published articles (read how Labome selects the articles), using MUL1 antibody in all methods. It is aimed to help Labome visitors find the most suited MUL1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MUL1 synonym: C1orf166; GIDE; MAPL; MULAN; RNF218; mitochondrial ubiquitin ligase activator of NFKB 1; E3 SUMO-protein ligase MUL1; E3 ubiquitin ligase; E3 ubiquitin-protein ligase MUL1; RING-type E3 ubiquitin transferase NFKB 1; growth inhibition and death E3 ligase; mitochondria-anchored protein ligase; mitochondrial E3 ubiquitin ligase 1; mitochondrial ubiquitin ligase activator of NF-kB; mitochondrial-anchored protein ligase; ring finger protein 218

Abcam
rabbit polyclonal
  • western blot; mouse; fig 3
Abcam MUL1 antibody (abcam, ab84067) was used in western blot on mouse samples (fig 3). Autophagy (2014) ncbi
Sigma-Aldrich
rabbit polyclonal
  • western blot; human; loading ...; fig 6a
In order to find that a subset of SLC25A46 interacts with mitochondrial dynamics components and the MICOS complex, Sigma-Aldrich MUL1 antibody (Sigma, HPA017681) was used in western blot on human samples (fig 6a). Mol Biol Cell (2017) ncbi
Articles Reviewed
  1. Steffen J, Vashisht A, Wan J, Jen J, Claypool S, Wohlschlegel J, et al. Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria. Mol Biol Cell. 2017;28:600-612 pubmed publisher
  2. Furuya N, Ikeda S, Sato S, Soma S, Ezaki J, Oliva Trejo J, et al. PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation. Autophagy. 2014;10:631-41 pubmed publisher